Diabetes Spectrum
SJR1.293
US
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 1.293 | Q1 | 89.6% | |
| 2024 | — | — | 0.899 | Q2 | 81.4% | |
| 2023 | — | — | 0.709 | Q2 | 76.1% | |
| 2022 | — | — | 0.555 | Q2 | 69.6% | |
| 2021 | — | — | 0.745 | Q2 | 79.2% | |
| 2020 | — | — | 0.716 | Q2 | 76.7% | |
| 2019 | — | — | 0.670 | Q2 | 75.8% | |
| 2018 | — | — | 0.563 | Q2 | 68.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1040-9165
ISSN
1944-7353
country
coverage
2005-2025